Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.300
+0.040 (1.23%)
Nov 5, 2024, 3:49 PM EST - Market open
Fulcrum Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 86.7 | 25.56 | 35.1 | 35.41 | 57.05 | 96.71 | Upgrade
|
| Short-Term Investments | 187.08 | 210.66 | 167.82 | 182.75 | 55.86 | - | Upgrade
|
| Cash & Short-Term Investments | 273.78 | 236.22 | 202.92 | 218.16 | 112.91 | 96.71 | Upgrade
|
| Cash Growth | -1.58% | 16.41% | -6.99% | 93.21% | 16.75% | 32.85% | Upgrade
|
| Accounts Receivable | 2.33 | 0.54 | 0.23 | 3.64 | 2.53 | - | Upgrade
|
| Other Receivables | 1.2 | 1.71 | 0.85 | 0.47 | 0.18 | 0.11 | Upgrade
|
| Receivables | 3.53 | 2.25 | 1.08 | 4.11 | 2.71 | 0.11 | Upgrade
|
| Prepaid Expenses | 2.97 | 3.73 | 3.52 | 3.73 | 3.82 | 2.98 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.07 | 0.28 | Upgrade
|
| Total Current Assets | 280.29 | 242.2 | 207.52 | 226 | 119.51 | 100.08 | Upgrade
|
| Property, Plant & Equipment | 10.77 | 12.39 | 15.97 | 7.37 | 8.4 | 9.21 | Upgrade
|
| Other Long-Term Assets | 3.21 | 3.1 | 3.2 | 1.63 | 1.67 | 1.15 | Upgrade
|
| Total Assets | 294.26 | 257.69 | 226.69 | 235 | 129.58 | 110.44 | Upgrade
|
| Accounts Payable | 3.58 | 2.76 | 3.64 | 4.79 | 4.08 | 2.19 | Upgrade
|
| Accrued Expenses | 6.73 | 8.33 | 9.45 | 9.16 | 7.21 | 5.38 | Upgrade
|
| Current Portion of Leases | 2.08 | 2.19 | 2.6 | - | 0.02 | 0.05 | Upgrade
|
| Current Unearned Revenue | - | - | 0.93 | 4.71 | 14.91 | 3.99 | Upgrade
|
| Other Current Liabilities | 0.31 | 0.4 | 0.11 | 0.54 | 0.51 | 0.54 | Upgrade
|
| Total Current Liabilities | 12.7 | 13.68 | 16.73 | 19.2 | 26.73 | 12.14 | Upgrade
|
| Long-Term Leases | 7.57 | 8.63 | 10.82 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 2.97 | 6.01 | Upgrade
|
| Other Long-Term Liabilities | 0.2 | 0.2 | 0.2 | 4.26 | 4.7 | 5.14 | Upgrade
|
| Total Liabilities | 20.47 | 22.5 | 27.74 | 23.46 | 34.4 | 23.29 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 755.23 | 744.94 | 612.03 | 514.36 | 316.78 | 237.93 | Upgrade
|
| Retained Earnings | -481.13 | -509.67 | -412.34 | -302.47 | -221.62 | -150.8 | Upgrade
|
| Comprehensive Income & Other | -0.37 | -0.14 | -0.8 | -0.4 | -0 | - | Upgrade
|
| Total Common Equity | 273.79 | 235.19 | 198.94 | 211.54 | 95.18 | 87.15 | Upgrade
|
| Shareholders' Equity | 273.79 | 235.19 | 198.94 | 211.54 | 95.18 | 87.15 | Upgrade
|
| Total Liabilities & Equity | 294.26 | 257.69 | 226.69 | 235 | 129.58 | 110.44 | Upgrade
|
| Total Debt | 9.65 | 10.82 | 13.42 | - | 0.02 | 0.05 | Upgrade
|
| Net Cash (Debt) | 264.13 | 225.4 | 189.5 | 218.16 | 112.9 | 96.66 | Upgrade
|
| Net Cash Growth | -0.71% | 18.95% | -13.14% | 93.24% | 16.79% | 32.87% | Upgrade
|
| Net Cash Per Share | 4.26 | 3.68 | 4.21 | 6.17 | 4.45 | 8.75 | Upgrade
|
| Filing Date Shares Outstanding | 62.4 | 61.94 | 61.76 | 40.63 | 32.55 | 22.68 | Upgrade
|
| Total Common Shares Outstanding | 62.25 | 61.92 | 52.1 | 40.63 | 27.94 | 22.65 | Upgrade
|
| Working Capital | 267.59 | 228.52 | 190.79 | 206.8 | 92.79 | 87.94 | Upgrade
|
| Book Value Per Share | 4.40 | 3.80 | 3.82 | 5.21 | 3.41 | 3.85 | Upgrade
|
| Tangible Book Value | 273.79 | 235.19 | 198.94 | 211.54 | 95.18 | 87.15 | Upgrade
|
| Tangible Book Value Per Share | 4.40 | 3.80 | 3.82 | 5.21 | 3.41 | 3.85 | Upgrade
|
| Machinery | 10.61 | 10.68 | 10.24 | 9.15 | 7.84 | 6.77 | Upgrade
|
| Construction In Progress | - | - | 0.03 | - | 0.26 | 0.08 | Upgrade
|
| Leasehold Improvements | 7.12 | 7.1 | 7.1 | 6.29 | 6.21 | 6.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.